Novo and Lilly are competing to win the GLP-1 pill market as they prepare for Medicare coverage
Novo Nordisk and Eli Lilly took their GLP-1 pill battle to the preeminent obesity meeting this weekend as they prepare...
Health care industry
U.S. confirms second Texas screwworm case, Canada restricts livestock imports
Cattle are herded in a stable on June 5, 2026 in Dublin, Texas. Brandon Bell | Getty ImagesThe U.S. Department...
Flesh-eating screwworm is confirmed in the U.S., officials say
Cochliomyia hominivorax, the New World screw-worm fly, or screw-worm for short, is a species of parasitic fly that is well...
Eli Lilly's top dealmaker says don't be surprised to see more M&A that pushes Lilly into new areas
Jacob Van Naarden is busy. In addition to running Eli Lilly's oncology business, he's now responsible for finding the drugmaker's next...
Biotech takeover target Abivax sinks over 30% after bowel disease drug trial update
Shares of French biotech Abivax tumbled as much 32% after it reported fresh data on its lead asset, a drug...
Why Trump reversed course to fast-track psychedelic drugs for mental healthcare
Marie Phelan said she had never heard of MDMA before spotting a flyer seeking veterans suffering from post traumatic stress...
Replimune to resubmit twice-rejected drug for approval after FDA shakeup
Thomas Fuller | Lightrocket | Getty ImagesReplimune plans to resubmit its melanoma drug to the Food and Drug Administration for...
CDC says American tests positive for Ebola in Africa, risk in the U.S. remains low
A sign sits outside of the Centers for Disease Control and Prevention (CDC) Roybal campus in Atlanta, Georgia, U.S. March...
FDA shuffles top drug, biologics leaders in latest shakeup
The logo for the Food and Drug Administration is seen ahead of a news conference at the Health and Human...
CDC says there are no U.S. hantavirus cases currently, 41 people being monitored
In this photo illustration Hantavirus samples are seen in Ankara, Turkiye on May 6, 2026. Arman Onal | Anadolu |...
Biogen advances Alzheimer's drug to late-stage trial despite disappointing data
A Biogen facility in Cambridge, Massachusetts.Brian Snyder | ReutersBiogen plans to advance an experimental drug for Alzheimer's disease to late-stage...
Marty Makary resigns as FDA commissioner following industry and White House backlash
Food and Drug Administration Commissioner Marty Makary speaks during an announcement at the Department of Health and Human Services on...
MV Hondius hantavirus outbreak: A luxury expedition cruise boom and new world of remote travel risks
Remote expedition cruises to places like Antarctica and the Arctic are booming as affluent travelers increasingly seek out isolated, experience-driven...
Fitness wearable Whoop to offer on-demand clinician access to U.S. users
Whoop fitness wearable.Courtesy: WhoopWearable fitness tracker Whoop announced on Friday it will introduce in-app access to on-demand licensed clinicians for...
Wearable patches: How Barrière is trying to disrupt the supplement industry
The supplement industry has seen booming demand over the past few years as consumers increasingly focus on health and wellness.Along...
CVS blows past estimates, hikes outlook as insurance business outperforms
A screen displays the logo and trading information for CVS at the New York Stock Exchange, March 24, 2026.Jeenah Moon...
FDA commissioner defends agency's drug approval decisions after wave of backlash
U.S. Food and Drug Administration Commissioner Marty Makary defended himself in a CNBC interview aired Tuesday after months of pressure...
Danco Laboratories seeks Supreme Court stay of ruling pausing mail-order access to abortion drugs
An abortion rights activist holds a box of mifepristone during a rally in front of the US Supreme Court on...
Weight loss and hair loss: The growing hair treatment market from GLP-1s
When Branneisha Cooper first began taking GLP-1 injection Mounjaro in late 2022, she heard online that she could experience temporary...
Eli Lilly blows past quarterly estimates, hikes outlook as Zepbound and Mounjaro sales skyrocket
Eli Lilly on Thursday reported first-quarter earnings and revenue that blew past estimates and hiked its full-year sales outlook by...
